itraconazole has been researched along with DDD MPGNII in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Furman-Kuklińska, K; Myśliwiec, M; Naumnik, B | 1 |
Burke, DG; Emancipator, SN; Salata, RA; Smith, MC | 1 |
2 other study(ies) available for itraconazole and DDD MPGNII
Article | Year |
---|---|
Fungaemia due to Cryptococcus laurentii as a complication of immunosuppressive therapy--a case report.
Topics: Adult; Antifungal Agents; Cryptococcosis; Cryptococcus; Fluconazole; Fungemia; Glomerulonephritis, Membranoproliferative; Humans; Immunocompromised Host; Immunosuppressive Agents; Itraconazole; Male; Opportunistic Infections; Renal Insufficiency | 2009 |
Histoplasmosis and kidney disease in patients with AIDS.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antibodies, Fungal; Antifungal Agents; Antigen-Antibody Complex; Biopsy; Cholesterol; Diagnosis, Differential; Glomerulonephritis, Membranoproliferative; Histoplasmosis; Humans; Immunohistochemistry; Itraconazole; Kidney; Male; Middle Aged; Proteinuria; Serum Albumin | 1997 |